Cargando…

Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial

Aim: To compare the acceptability and efficacy of orally administered commercially available midazolam syrup and injection midazolam mixed in honey for performing venepuncture. Materials and methods: This double blind randomized controlled trial enrolled 40 anxious and healthy 2 to 6 years olds. All...

Descripción completa

Detalles Bibliográficos
Autores principales: Srivastava, Binita, Mittal, Neeti, Mittal, Parteek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335103/
https://www.ncbi.nlm.nih.gov/pubmed/25709292
http://dx.doi.org/10.5005/jp-journals-10005-1255
_version_ 1782358290519293952
author Srivastava, Binita
Mittal, Neeti
Mittal, Parteek
author_facet Srivastava, Binita
Mittal, Neeti
Mittal, Parteek
author_sort Srivastava, Binita
collection PubMed
description Aim: To compare the acceptability and efficacy of orally administered commercially available midazolam syrup and injection midazolam mixed in honey for performing venepuncture. Materials and methods: This double blind randomized controlled trial enrolled 40 anxious and healthy 2 to 6 years olds. All subjects received either syrup midazolam or injection midazolam mixed in honey (0.5 mg/kg) per orally, prior to venepuncture as per their group assignment. Primary outcome measures in this trial was acceptability of midazolam. Secondary outcome measures included sedation depth, success of venepuncture, observer and parental satisfaction and parental perception of child's pain. Results: Although the acceptability of syrup midazolam (95%) was higher than injection midazolam (80%), there was no significant difference among two groups with respect to any primary or secondary outcome (p > 0.05). Conclusion: Syrup midazolam can serve as a suitable alternative to injection midazolam; thus, eliminating the procedural steps of mixing injection midazolam with any vehicle. How to cite this article: Srivastava B, Mittal N, Mittal P. Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial. Int J Clin Pediatr Dent 2014;7(3):153-156.
format Online
Article
Text
id pubmed-4335103
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Jaypee Brothers Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-43351032015-02-23 Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial Srivastava, Binita Mittal, Neeti Mittal, Parteek Int J Clin Pediatr Dent Research Article Aim: To compare the acceptability and efficacy of orally administered commercially available midazolam syrup and injection midazolam mixed in honey for performing venepuncture. Materials and methods: This double blind randomized controlled trial enrolled 40 anxious and healthy 2 to 6 years olds. All subjects received either syrup midazolam or injection midazolam mixed in honey (0.5 mg/kg) per orally, prior to venepuncture as per their group assignment. Primary outcome measures in this trial was acceptability of midazolam. Secondary outcome measures included sedation depth, success of venepuncture, observer and parental satisfaction and parental perception of child's pain. Results: Although the acceptability of syrup midazolam (95%) was higher than injection midazolam (80%), there was no significant difference among two groups with respect to any primary or secondary outcome (p > 0.05). Conclusion: Syrup midazolam can serve as a suitable alternative to injection midazolam; thus, eliminating the procedural steps of mixing injection midazolam with any vehicle. How to cite this article: Srivastava B, Mittal N, Mittal P. Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial. Int J Clin Pediatr Dent 2014;7(3):153-156. Jaypee Brothers Medical Publishers 2014 2015-02-09 /pmc/articles/PMC4335103/ /pubmed/25709292 http://dx.doi.org/10.5005/jp-journals-10005-1255 Text en Copyright © 2014; Jaypee Brothers Medical Publishers (P) Ltd. This work is licensed under a Creative Commons Attribution 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by/3.0/
spellingShingle Research Article
Srivastava, Binita
Mittal, Neeti
Mittal, Parteek
Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial
title Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial
title_full Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial
title_fullStr Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial
title_full_unstemmed Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial
title_short Acceptability and Efficacy of Commercial Oral Preparation of Midazolam for brief Painful Procedure: A Randomized Double Blind Clinical Trial
title_sort acceptability and efficacy of commercial oral preparation of midazolam for brief painful procedure: a randomized double blind clinical trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335103/
https://www.ncbi.nlm.nih.gov/pubmed/25709292
http://dx.doi.org/10.5005/jp-journals-10005-1255
work_keys_str_mv AT srivastavabinita acceptabilityandefficacyofcommercialoralpreparationofmidazolamforbriefpainfulprocedurearandomizeddoubleblindclinicaltrial
AT mittalneeti acceptabilityandefficacyofcommercialoralpreparationofmidazolamforbriefpainfulprocedurearandomizeddoubleblindclinicaltrial
AT mittalparteek acceptabilityandefficacyofcommercialoralpreparationofmidazolamforbriefpainfulprocedurearandomizeddoubleblindclinicaltrial